LONG-TERM HEALTH OUTCOMES AND QUALITY-OF-LIFE IN AMERICAN AND ITALIANINCEPTION COHORTS OF PATIENTS WITH JUVENILE RHEUMATOID-ARTHRITIS .1. OUTCOME STATUS

Citation
N. Ruperto et al., LONG-TERM HEALTH OUTCOMES AND QUALITY-OF-LIFE IN AMERICAN AND ITALIANINCEPTION COHORTS OF PATIENTS WITH JUVENILE RHEUMATOID-ARTHRITIS .1. OUTCOME STATUS, Journal of rheumatology, 24(5), 1997, pp. 945-951
Citations number
25
Categorie Soggetti
Rheumatology
Journal title
ISSN journal
0315162X
Volume
24
Issue
5
Year of publication
1997
Pages
945 - 951
Database
ISI
SICI code
0315-162X(1997)24:5<945:LHOAQI>2.0.ZU;2-K
Abstract
Objective. To assess the longterm health outcomes and quality of life of patients with juvenile rheumatoid arthritis (JRA) using health and functional assessment questionnaires in 2 populations, one from the US A and one from Italy. Methods. Patient eligibility criteria: (1) first examined in our units between 1958 and 1990 during the first 6 months after onset of symptoms, (2) diagnosis of JRA by the American College of Rheumatology criteria, (3) disease duration of at least 5 years at the time of assessment of outcome, Instruments used: (1) the Health A ssessment Questionnaire (HAQ, short form, or childhood HAQ (CHAQ), and (2) Quality of Life Scales (QOLS, adults only), Eligible patients wer e identified by computer search and chart review and were then mailed a packet containing a consent/assent form and the assessment instrumen ts. Results. Of 346 patients who met the eligibility criteria we were able to locate 301, and 290 verbally agreed to participate and were ma iled packets. Signed consent and complete information were received fr om 227 of the 290 (78%), 178 from the USA and 49 from Italy. Mean dura tion of disease at the time of outcome assessment was 15 yrs. 127 had pauciarticular, 55 polyarticular, and 45 systemic onset disease. Mean and (median) scores of the outcomes are shown in the table. [GRAPHICS] Conclusion. Longterm outcome, as assessed by the instruments used, is very favorable in most patients with JRA 5 years or more after onset of symptoms.